EARLY MECHANISMS OF HIV TRANSMISSION USING THE SIV/MACAQUE MODEL FOR AIDS
使用艾滋病病毒/猕猴模型研究艾滋病毒传播的早期机制
基本信息
- 批准号:8172686
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAccountingAcquired Immunodeficiency SyndromeCD4 Positive T LymphocytesCellsComputer Retrieval of Information on Scientific Projects DatabaseDendritic CellsDevelopmentDissectionEpidemicFundingGenerationsGenital systemGrantHIVHumanImmune responseImmunizationIn SituInfectionInstitutionKnowledgeLymphocyteMacacaMacaca fascicularisMethodsModelingPathway interactionsPhenotypeResearchResearch PersonnelResourcesSIVSexual TransmissionSiteSourceSterilitySurfaceTimeUnited States National Institutes of HealthVaccinesVaginaViralVirus Diseasescell typeintraepithelialmacrophagemucosal sitenovel vaccinespreventrectalsuccesstransmission processvaginal transmission
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Sexual transmission of human immunodeficiency virus (HIV) accounts for the majority of new infections worldwide. A vaccine capable of preventing sexual transmission across genital or rectal mucosal surfaces could provide a method for stopping the AIDS epidemic. The ultimate success of strategies to prevent sexual transmission of HIV depends, in part, on a better understanding of the virological and immunological mechanisms that underlie sexual transmission. Numerous studies have demonstrated the difficulty to achieve sterile protection from vaginally or rectally acquired HIV/SIV using parenteral immunization. Mucosal immunization is seen as the best approach to achieve sustainable immune responses at mucosal sites of viral entry. Defining the mechanisms of vaginal HIV transmission, in particular the initial immune response is central to the development of effective strategies to develop a successful mucosal AIDS vaccine. Our knowledge of the initial target cells involved in mucosal transmission is still evolving. Increasing evidence suggests that the initial site of productive infection occurs in situ at the mucosal surface. Studies of vaginal transmission suggest that the potential initial target cell may be either activated CD4+ T cells or intraepithelial dendritic cells. Precise dissection of viral targets and pathways involved in sexual HIV transmission will prove essential to the global effort to develop a protective vaccine. The identification of initial target cells and the ability to elicit and to enhance cellular or humoral immune responses at mucosal sites is likely to be a crucial step in the development of novel vaccines. These questions are extremely difficult to pursue experimentally in humans. In this study we propose to examine in situ viral infection at mucosal portal of entry in the SIV/cynomolgus (Macaca fascicularis) macaque model using SIV tagged with GFP. Specific aims will include: 1) To identify the types of cells initially infected (i.e., lymphocytes, macrophages, and dendritic cells), their phenotype and function; 2) To investigate the mechanisms, time course, and pathways of viral spread from site of initial infection; and, 3) To explore generation of early mucosal cellular immune response at vaginal site of SIV infection.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目及
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
人类免疫缺陷病毒(HIV)的性传播占全球新增感染的大部分。一种能够防止通过生殖器或直肠粘膜表面进行性传播的疫苗可以提供一种阻止艾滋病流行的方法。预防艾滋病毒性传播策略的最终成功部分取决于对性传播背后的病毒学和免疫学机制的更好理解。大量研究表明,通过肠外免疫很难实现针对阴道或直肠感染 HIV/SIV 的无菌保护。粘膜免疫被视为在病毒进入粘膜部位实现可持续免疫反应的最佳方法。确定艾滋病毒阴道传播的机制,特别是初始免疫反应,对于制定成功的粘膜艾滋病疫苗的有效策略至关重要。我们对参与粘膜传播的初始靶细胞的了解仍在不断发展。越来越多的证据表明,生产性感染的初始部位发生在粘膜表面原位。阴道传播的研究表明,潜在的初始靶细胞可能是活化的 CD4+ T 细胞或上皮内树突状细胞。精确剖析涉及艾滋病毒性传播的病毒靶标和途径对于全球开发保护性疫苗的努力至关重要。初始靶细胞的识别以及在粘膜部位引发和增强细胞或体液免疫反应的能力可能是开发新型疫苗的关键步骤。这些问题在人类身上进行实验是极其困难的。在这项研究中,我们建议使用带有 GFP 标记的 SIV 来检查 SIV/食蟹猴(Macaca fasciculis)猕猴模型中粘膜入口处的原位病毒感染。 具体目标包括: 1) 确定最初感染的细胞类型(即淋巴细胞、巨噬细胞和树突状细胞)、它们的表型和功能; 2)研究病毒从初始感染部位传播的机制、时间过程和途径; 3) 探索 SIV 感染阴道部位早期粘膜细胞免疫反应的产生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marie-Claire Elisabeth Gauduin其他文献
Marie-Claire Elisabeth Gauduin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marie-Claire Elisabeth Gauduin', 18)}}的其他基金
Durable HIV Vaccine Targeting Mucosal Epithelium
针对粘膜上皮的耐用 HIV 疫苗
- 批准号:
10548066 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Durable HIV Vaccine Targeting Mucosal Epithelium
针对粘膜上皮的耐用 HIV 疫苗
- 批准号:
10675701 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
A Neonatal Monkey Model of Tuberculosis Vaccination
新生猴结核病疫苗接种模型
- 批准号:
9901954 - 财政年份:2019
- 资助金额:
$ 1.92万 - 项目类别:
A Neonatal Monkey Model for Tuberculosis Vaccination
结核病疫苗接种的新生猴模型
- 批准号:
9201694 - 财政年份:2017
- 资助金额:
$ 1.92万 - 项目类别:
Recombinant Papillomavirus-based HIV Vaccine Targeting Genital Mucosa
针对生殖器粘膜的基于重组乳头瘤病毒的 HIV 疫苗
- 批准号:
8993591 - 财政年份:2015
- 资助金额:
$ 1.92万 - 项目类别:
Trans-complementing papillioma virus for AIDS vaccine
用于艾滋病疫苗的反式互补乳头状瘤病毒
- 批准号:
9011505 - 财政年份:2015
- 资助金额:
$ 1.92万 - 项目类别:
EFFICACY OF A DNA/MVA VACCINE TO PROTECT AGAINST REPEATED VAGINAL SIV CHALLENGE
DNA/MVA 疫苗预防反复阴道 SIV 攻击的功效
- 批准号:
8357926 - 财政年份:2011
- 资助金额:
$ 1.92万 - 项目类别:
EPITHELIAL CELLS AS MUCOSAL ADJUVANT FOR LIFE LONG IMMUNITY
上皮细胞作为终身免疫的粘膜佐剂
- 批准号:
8357687 - 财政年份:2011
- 资助金额:
$ 1.92万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别: